Recognizing IPMN-derived pancreatic cancer as a specific entity requiring prospective clinical studies: a call for international collaboration

J Natl Cancer Inst. 2025 May 1;117(5):1084-1085. doi: 10.1093/jnci/djaf037.

Authors

Joseph R Habib^{1

2}, Ammar A Javed^{1

3

4}, I Quintus Molenaar², Christopher L Wolfgang¹, Marc G Besselink^{3

4}; PANC-PALS consortium

Collaborators

PANC-PALS consortium:
Camila Hidalgo Salinas, Ingmar F Rompen, Brady A Campbell, D Brock Hewitt, Lois A Daamen, Greg D Sacks, Katherine Morgan, Jin He

Affiliations

¹ Department of Surgery, New York University Langone Health, New York, NY 10016, United States.
² Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center & St Antonius Hospital Nieuwegein, Utrecht 3584 CX, The Netherlands.
³ Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
⁴ Cancer Center Amsterdam, Amsterdam 1081 HV, The Netherlands.

PMID: 39945800
DOI: 10.1093/jnci/djaf037

No abstract available